Direct Measurement of Lead in Bone: A Promising Biomarker
-
1994/01/19
Details
-
Personal Author:
-
Description:Chronic excessive exposure to lead is widespread in industrialized societies. In the United States, an estimated 3 million young children have a blood lead level of 0.50 umol/L(10 ug/dL)or more, the level considered by the Centers for Disease Control and Prevention to indicate increased absorption. Also, more than 1.4 million industrial workers have the potential for chronic exposure through occupations such as stained glass manufacturing, battery making, and bridge Despite the extent of this exposure, great gaps exist in our knowledge of the chronic toxicity of lead. For example, we do not know the level of cumulative exposure in adults that is associated with chronic dysfunction of the central or peripheral nervous systems. We do not know whether chronic exposure is associated with motor neuron disease, parkinsonism, or other chronic neurological illnesses. We do not know the fraction of hypertension or of renal failure that may be attributable to elevated lead levels. In women, we know little about the toxic consequences of the lead mobilization that may occur during pregnancy, lactation, and menopause. In men, we do not know the level of exposure that may be associated with disordered spermatogenesis or other reproductive dysfunctions. Lack of a sensitive and specific biologic marker of cumulative exposure has long been an impediment to research in this field. The fundamental problem is that the blood lead level, the traditional index of absorption, reflects only relatively recent exposure because the half-life of lead in blood is only about 36 days. In persons with chronic exposure, there is little correlation between a single, randomly obtained blood lead level and either a cumulative index of absorption or the body lead burden. Now comes a technology-x-ray fluorescence (XRF) analysis of lead in bone-that appears to hold substantial promise for overcoming those limitations. The XRF technique, as reported in this issue of THE JOURNAL by Kosnett et al, takes advantage of the fact that absorbed lead is stored in bone and has a half-life in dense cortical bone of at least 25 years. Thus, it is hypothesized that direct measurement of lead in bone will provide data on cumulative past exposure and that these data will be useful for epidemiologic analysis as well as for clinical assessment. The XRF technique is noninvasive, relatively quick, and involves less than 2.5% of the radiation of a chest x-ray examination. demolishing. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0098-7484
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Pages in Document:239-240
-
Volume:271
-
Issue:3
-
NIOSHTIC Number:nn:20059910
-
Citation:JAMA 1994 Jan; 271(3):239-240
-
Contact Point Address:Dr Landrigan, Department of Community Medicine, Mount Sinai School of Medicine, New York, NY 10029-6574
-
CAS Registry Number:
-
Federal Fiscal Year:1994
-
Performing Organization:Mount Sinai School of Medicine, New York
-
Peer Reviewed:False
-
Start Date:19920701
-
Source Full Name:Journal of the American Medical Association
-
End Date:19970630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:45adb82ec23a0b01890b59fb1b5b0315b2705fb59e9f0fb15590fc509b581065ff862fc71911239392f8d57a4af3dd67e136ae13993a5dd0bca5fdcd0ef9acfc
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like